Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily Lin

Showing results (81-90 of 99) with videos related to

Pageof 10
Sort By:
Bioorganic & Medicinal Chemistry Letters|November 16, 2010
Discovery of NBI-77860/GSK561679, a potent corticotropin-releasing factor (CRF1) receptor antagonist with improved pharmacokinetic propertiesJohn E Tellew, Marion Lanier, Manisha Moorjani, et al.
Nano Letters|March 29, 2023
Plasmonic Response of Complex Nanoparticle AssembliesZachary M Sherman, Kihoon Kim, Jiho Kang, et al.
The American Journal of Pathology|September 13, 2020
Kupffer Cells: Inflammation Pathways and Cell-Cell Interactions in Alcohol-Associated Liver DiseaseElise Slevin, Leonardo Baiocchi, Nan Wu, et al.
Journal of Rnai and Gene Silencing : an International Journal of RNA and Gene Targeting Research|September 23, 2009
Delivery of RNAi reagents in murine models of obesity and diabetesDenise M Wilcox, Ruojing Yang, Sherry J Morgan, et al.
The Journal of Biological Chemistry|June 7, 2007
Liver-specific knockdown of JNK1 up-regulates proliferator-activated receptor gamma coactivator 1 beta and increases plasma triglyceride despite reduced glucose and insulin levels in diet-induced obese miceRuojing Yang, Denise M Wilcox, Deanna L Haasch, et al.
Bioorganic & Medicinal Chemistry Letters|October 7, 2008
2,6-Diaryl-4-acylaminopyrimidines as potent and selective adenosine A(2A) antagonists with improved solubility and metabolic stabilityManisha Moorjani, Zhiyong Luo, Emily Lin, et al.
Bioorganic & Medicinal Chemistry Letters|February 6, 2008
2,6-Diaryl-4-phenacylaminopyrimidines as potent and selective adenosine A(2A) antagonists with reduced hERG liabilityManisha Moorjani, Xiaohu Zhang, Yongsheng Chen, et al.
Molecular Cell|September 21, 2021
Inositol serves as a natural inhibitor of mitochondrial fission by directly targeting AMPKChe-Chia Hsu, Xian Zhang, Guihua Wang, et al.
British Journal of Haematology|May 3, 2019
Multicentre retrospective study of intravascular large B-cell lymphoma treated at academic institutions within the United StatesMarcus Geer, Emily Roberts, Maryann Shango, et al.
Bioorganic & Medicinal Chemistry Letters|March 11, 2008
Synthesis of N-pyrimidinyl-2-phenoxyacetamides as adenosine A2A receptor antagonistsXiaohu Zhang, Jaimie K Rueter, Yongsheng Chen, et al.
Pageof 10

Showing results (81-90 of 99) with videos related to

Sort By:
Pageof 10
Bioorganic & Medicinal Chemistry Letters|November 16, 2010
Discovery of NBI-77860/GSK561679, a potent corticotropin-releasing factor (CRF1) receptor antagonist with improved pharmacokinetic propertiesJohn E Tellew, Marion Lanier, Manisha Moorjani, et al.
Nano Letters|March 29, 2023
Plasmonic Response of Complex Nanoparticle AssembliesZachary M Sherman, Kihoon Kim, Jiho Kang, et al.
The American Journal of Pathology|September 13, 2020
Kupffer Cells: Inflammation Pathways and Cell-Cell Interactions in Alcohol-Associated Liver DiseaseElise Slevin, Leonardo Baiocchi, Nan Wu, et al.
Journal of Rnai and Gene Silencing : an International Journal of RNA and Gene Targeting Research|September 23, 2009
Delivery of RNAi reagents in murine models of obesity and diabetesDenise M Wilcox, Ruojing Yang, Sherry J Morgan, et al.
The Journal of Biological Chemistry|June 7, 2007
Liver-specific knockdown of JNK1 up-regulates proliferator-activated receptor gamma coactivator 1 beta and increases plasma triglyceride despite reduced glucose and insulin levels in diet-induced obese miceRuojing Yang, Denise M Wilcox, Deanna L Haasch, et al.
Bioorganic & Medicinal Chemistry Letters|October 7, 2008
2,6-Diaryl-4-acylaminopyrimidines as potent and selective adenosine A(2A) antagonists with improved solubility and metabolic stabilityManisha Moorjani, Zhiyong Luo, Emily Lin, et al.
Bioorganic & Medicinal Chemistry Letters|February 6, 2008
2,6-Diaryl-4-phenacylaminopyrimidines as potent and selective adenosine A(2A) antagonists with reduced hERG liabilityManisha Moorjani, Xiaohu Zhang, Yongsheng Chen, et al.
Molecular Cell|September 21, 2021
Inositol serves as a natural inhibitor of mitochondrial fission by directly targeting AMPKChe-Chia Hsu, Xian Zhang, Guihua Wang, et al.
British Journal of Haematology|May 3, 2019
Multicentre retrospective study of intravascular large B-cell lymphoma treated at academic institutions within the United StatesMarcus Geer, Emily Roberts, Maryann Shango, et al.
Bioorganic & Medicinal Chemistry Letters|March 11, 2008
Synthesis of N-pyrimidinyl-2-phenoxyacetamides as adenosine A2A receptor antagonistsXiaohu Zhang, Jaimie K Rueter, Yongsheng Chen, et al.
Pageof 10